Search - tctmd.com

Displaying 441 - 460 of 925

Sort: Relevancy | Date

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Industry News

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

September 14, 2014

News Industry News

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

September 14, 2014

News Industry News

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

September 14, 2014

News Conference News TCT 2014

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Industry News

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

September 11, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

Advertisement

Keynote Address Focuses on Newer DES, Problematic Subgroups

COMBO Stent Achieves Neointimal Regression at 24 Months

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

PROTECT: ZES Sustain Lead Over SES at 5 Years

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content